rmc-6236
revolution medicines
['lcsm,(-blcsm)', 'rmc-6236']
updated and comprehensive summary by prof. pasi janne. from an overview of strategies to target kras to the newest agents and combinations. promising early study results by pan-ras on inhibitor, rmc-6236, covering a wide variety of kras mutants (g12c/d/r/s/v...). #aacr23 #lcsm 
Medical Oncologist, National Cancer Center Hospital, Lung Cancer Study Group @JCOG_official, Educational Committee @JSMO_official, @JLCS_OFFICIAL, @IASLC